Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 28/04/2023 11:27:53 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2023 EPS = 1.35 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 430.562 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 663.242 |
| 09/02/2023 15:44:11 | BOOK CLOSURE TO 24/05/2023 ANNUAL GENERAL MEETING HELD ON 24/05/2023 EPS = 7.73 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,462.892 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 5,105.641 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2022 BOOK CLOSURE FROM 18/05/2023 |
| 26/10/2022 11:21:06 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,484.708 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2022 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 779.876 EPS = 2.45 |
| 23/08/2022 15:02:08 | EPS = 1.98 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 631.212 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,202.372 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2022 |
| 07/06/2022 10:26:13 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,386.462 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 925.041 EPS = 2.90 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2022 |